Celecoxib Japan Observational Study for the Patients With Acute Pain

Astellas

Status: Completed

Conditions: Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain

Treatments: Drug: Celecoxib

Study type: Observational

Funder types: Industry

Identifiers

NCT01876121

COX-05

Details and patient eligibility

About

This study is to assess the safety and efficacy of celecoxib on the pain relief from acute pain.

Full description

Patients with traumatic pain, post-surgical and tooth extract pain will be included in this study. Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the safety will be evaluated.

Enrollment: 784 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with traumatic pain, post-surgical pain and tooth extract pain

Exclusion criteria

• Hyperreactive to sulfonamide
• Aspirin asthma patients
• Peptidic ulcer patients
• Serious liver disease patients
• Serious kidney disease patients
• Serious heart failure patients
• End of pregnancy

Trial design

784 participants in 1 patient group

Celecox group

Treatment:

Drug: Celecoxib